Metastasis is the major cause of death in patients with colorectal carcinoma (CRC). The
most common sites of metastasis are the liver and the peritoneum. Peritoneal …

Peritoneal metastases (PM) from colorectal cancer (CRC) were traditionally associated with
bad prognosis. Only recently, cytoreductive surgery (CRS) with hyperthermic intraperitoneal …

A significant proportion of colorectal cancer (CRC) patients develop peritoneal metastases
(PM) in the course of their disease. PMs are associated with a poor quality of life, significant …

Peritoneal dissemination is a frequent metastatic route for cancers of the ovary and
gastrointestinal tract. Tumour cells metastasize by attaching to and invading through the …

OBJECTIVE: Assess the overall outcome in colorectal cancer (CRC) patients that present
with a combination of peritoneal metastases (PM) and liver metastases (CRLM) after …

Solid tumors are complex and unstructured organs that, in addition to cancer cells, also
contain other cell types. Carcinoma-associated fibroblasts (CAFs) represent an important …

Peritoneal metastasis is an insidious aspect of colorectal cancer. The aim of the present
study was to define mechanisms regulating colon cancer cell adhesion and spread to …

Peritoneal dissemination is diagnosed in 10–25% of colorectal cancer patients. Selected
patients are treated with cytoreductive surgery and hyperthermic intraperitoneal …

Abstract Background and Objectives CytoReductive Surgery (CRS) combined with
Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) has an established role in the …

Introduction With evolving treatment strategies aiming at prevention or early detection of
metachronous peritoneal metastases (PM), identification of high-risk colon cancer patients …